Coris BioConcept is a leading expert in the field of rapid diagnostics kits. Based in Belgium and established in 1996, the company develops, produces and markets diagnostic kits, mainly for the detection of human infectious pathogens (bacteria, virus and parasites), and for the detection of antibiotic resistance markers. These rapid tests are based on the immunochromatographic (also known as lateral flow), the isothermal LAMP and the electrochemical technologies and are extensively used in microbiology laboratories worldwide. Coris BioConcept is currently involved in multiple collaborative international projects (including Belgian and/or European grants) for the development of new rapid diagnostic assays, with focus on antimicrobial resistance and neglected tropical and emerging diseases. This R&D expertise is ideally suited for the “on-demand” development or production of innovative solutions in a rapidly changing world that calls for cutting edge biotechnology to take us forward into a healthy future. All Coris BioConcept’s products fulfill the CE marking requirements and the company is also certified ISO 13485.
Looking for a particular CORIS BIOCONCEPT employee's phone or email?
The CORIS BIOCONCEPT annual revenue was $5.6 million in 2026.
Sebastien Goenen is the CEO of CORIS BIOCONCEPT.
29 people are employed at CORIS BIOCONCEPT.
CORIS BIOCONCEPT is based in Gembloux, Wallonia.
The NAICS codes for CORIS BIOCONCEPT are [54171, 541713, 5417, 54, 541].
The SIC codes for CORIS BIOCONCEPT are [87, 873].